Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00550290 · ClinicalTrials.gov registry record · Phase 4
Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy
A Phase 4 study, sponsored by Aultman Health Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
NCT00550290 is a Phase 4 study that has completed, run by Aultman Health Foundation. The registered enrollment target is 18 participants.
The verdict
NCT00550290, a Phase 4 study, has completed, sponsored by Aultman Health Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
Study Summary
This randomized prospective study will specifically investigate the efficacy of a 24 hour post-operative course of broad-spectrum prophylactic antibiotics - namely Cefazolin - in preventing wound infection and wound breakdown following vulvectomy.
Interventions
- DRUG Cefazolin PostOperatively
- DRUG Cefazolin Preoperatively
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00550290
The ClinicalTrials.gov registry entry for NCT00550290 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aultman Health Foundation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cefazolin PostOperatively is the first listed.
NCT00550290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00550290 about?
NCT00550290 is a clinical study titled "Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy". This randomized prospective study will specifically investigate the efficacy of a 24 hour post-operative course of broad-spectrum prophylactic antibiotics - namely Cefazolin - in preventing wound infection and wound breakdown following vulvectomy.
What is the current status of trial NCT00550290?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2007-10. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00550290?
The interventions under investigation include: Cefazolin PostOperatively (DRUG), Cefazolin Preoperatively (DRUG).
Who is sponsoring clinical trial NCT00550290?
This trial is sponsored by Aultman Health Foundation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.